Gene · 7014
Papers3,508
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,508
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers. | Onco Targets Ther | 2024 | 38855632 | PubTator, text mining | PubMed |
| Fate of telomere entanglements is dictated by the timing of anaphase midregion nuclear envelope breakdown. | Nat Commun | 2024 | 38830842 | PubTator, text mining | PubMed |
| Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1. | Aging (Albany NY) | 2024 | 38829772 | PubTator, text mining | PubMed |
| The protective effects of Chromofungin in oligomeric amyloid β42 (Aβ42)-induced toxicity in neurons in Alzheimer's disease. | Aging (Albany NY) | 2024 | 38795392 | PubTator, text mining | PubMed |
| Characterization of telomere variant repeats using long reads enables allele-specific telomere length estimation. | BMC Bioinformatics | 2024 | 38755561 | PubTator, text mining | PubMed |
| Investigating the Relationship between Telomere-Related Gene Variants and Leukocyte Telomere Length in Optic Neuritis Patients. | J Clin Med | 2024 | 38731223 | PubTator, text mining | PubMed |
| Clinical mutations in the TERT and TERC genes coding for telomerase components induced oxidative stress, DNA damage at telomeres and cell apoptosis besides decreased telomerase activity. | Hum Mol Genet | 2024 | 38641551 | PubTator, text mining | PubMed |
| Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2). | J Biochem Mol Toxicol | 2024 | 38613465 | PubTator, text mining | PubMed |
| Caenorhabditis elegans telomere-binding proteins TEBP-1 and TEBP-2 adapt the Myb module to dimerize and bind telomeric DNA. | Proc Natl Acad Sci U S A | 2024 | 38588418 | PubTator, text mining | PubMed |
| Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer. | Cancer Genet | 2024 | 38503134 | PubTator, text mining | PubMed |
| Aging Processes Are Affected by Energy Balance: Focused on the Effects of Nutrition and Physical Activity on Telomere Length. | Curr Nutr Rep | 2024 | 38498288 | PubTator, text mining | PubMed |
| TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication. | J Exp Clin Cancer Res | 2024 | 38459559 | PubTator, text mining | PubMed |
| DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38430974 | PubTator, text mining | PubMed |
| DNA-PK controls Apollo's access to leading-end telomeres. | Nucleic Acids Res | 2024 | 38407308 | PubTator, text mining | PubMed |
| Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions. | Curr Cancer Drug Targets | 2024 | 38357955 | PubTator, text mining | PubMed |
| Preferential formation of Z-RNA over intercalated motifs in long noncoding RNA. | Genome Res | 2024 | 38355305 | PubTator, text mining | PubMed |
| The Influence of Telomere-Related Gene Variants, Serum Levels, and Relative Leukocyte Telomere Length in Pituitary Adenoma Occurrence and Recurrence. | Cancers (Basel) | 2024 | 38339395 | PubTator, text mining | PubMed |
| Special Issue "Deployment of Proteomics Approaches in Biomedical Research". | Int J Mol Sci | 2024 | 38338994 | PubTator, text mining | PubMed |
| The cross talk between type II diabetic microenvironment and the regenerative capacities of human adipose tissue-derived pericytes: a promising cell therapy. | Stem Cell Res Ther | 2024 | 38331889 | PubTator, text mining | PubMed |
| Exploring TRF2-Dependent DNA Distortion Through Single-DNA Manipulation Studies. | Commun Biol | 2024 | 38310140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7014/papers?page=7